InMed Pharmaceuticals (INM) has released an update to notify the public and investors about its officers.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
InMed Pharmaceuticals Inc. has appointed Ms. N. Netta “Neeta” Jagpal as Chief Financial Officer and Corporate Secretary, effective February 20, 2024. Ms. Jagpal will assume the responsibilities of the top financial roles in the company and will be compensated with a base salary of CAD$325,000 plus potential bonuses and stock options based on company performance and board approval. Her appointment comes with an employment agreement detailing her tenure and incentives, replacing Mr. Jonathan Tegge, who will step down from his interim CFO role on the same date.
For further insights into INM corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
